These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic value of diffusion-weighted imaging and Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267 [TBL] [Abstract][Full Text] [Related]
3. Assessment of metastatic lymph nodes in head and neck squamous cell carcinomas using simultaneous Chen J; Hagiwara M; Givi B; Schmidt B; Liu C; Chen Q; Logan J; Mikheev A; Rusinek H; Kim SG Sci Rep; 2020 Nov; 10(1):20764. PubMed ID: 33247166 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of FDG PET/MRI for cervical lymph node metastasis in patients with clinically N0 head and neck cancer. Cebeci S; Aydos U; Yeniceri A; Pula D; Duzlu M; Atay LO; Yilmaz M Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4528-4535. PubMed ID: 37259734 [TBL] [Abstract][Full Text] [Related]
5. FDG PET/MR for lymph node staging in head and neck cancer. Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792 [TBL] [Abstract][Full Text] [Related]
6. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma. Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897 [TBL] [Abstract][Full Text] [Related]
7. Utility of SUV Lim RS; Ramdave S; Beech P; Billah B; Karim MN; Smith JA; Safdar A; Sigston E Cancer Imaging; 2016 Nov; 16(1):39. PubMed ID: 27821180 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of ultrasound, ¹⁸F-FDG-PET/CT, and fused ¹⁸F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC. Heusch P; Sproll C; Buchbender C; Rieser E; Terjung J; Antke C; Boeck I; Macht S; Scherer A; Antoch G; Heusner TA; Handschel J Clin Oral Investig; 2014 Apr; 18(3):969-78. PubMed ID: 23892450 [TBL] [Abstract][Full Text] [Related]
10. Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC). Freihat O; Pinter T; Kedves A; Sipos D; Cselik Z; Repa I; Kovács Á Cancer Imaging; 2020 Aug; 20(1):56. PubMed ID: 32771060 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis. Kim SJ; Pak K; Kim K Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166 [TBL] [Abstract][Full Text] [Related]
12. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help? Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805 [TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Adams S; Baum RP; Stuckensen T; Bitter K; Hör G Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374 [TBL] [Abstract][Full Text] [Related]
14. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous Pyatigorskaya N; De Laroche R; Bera G; Giron A; Bertolus C; Herve G; Chambenois E; Bergeret S; Dormont D; Amor-Sahli M; Kas A AJNR Am J Neuroradiol; 2020 Oct; 41(10):1888-1896. PubMed ID: 32972956 [TBL] [Abstract][Full Text] [Related]
15. Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients. Peltenburg B; de Keizer B; Dankbaar JW; de Boer M; Willems SM; Philippens MEP; Terhaard CHJ; de Bree R Acta Oncol; 2018 Dec; 57(12):1687-1692. PubMed ID: 30489180 [TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of the impact of human papilloma virus status and small node size on the diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for primary head and neck squamous cell carcinoma. Lee J; Emmett L; Tang R; Ho B; Earls P; Matthews T; Gallagher R ANZ J Surg; 2020 Jul; 90(7-8):1396-1401. PubMed ID: 32564498 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822 [TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804 [TBL] [Abstract][Full Text] [Related]
20. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI. Schaarschmidt BM; Heusch P; Buchbender C; Ruhlmann M; Bergmann C; Ruhlmann V; Schlamann M; Antoch G; Forsting M; Wetter A Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):92-102. PubMed ID: 26243264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]